Work

SAT-263 Resmetirom treatment of a subgroup of patients with possible MetALD enrolled in MAESTRO-NASH, a phase 3 NASH/MASH serial liver biopsy study

Year: 2024

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(24)00708-6

Authors: Stephen A. Harrison, Jörn M. Schattenberg, Rebecca Taub, Dominic Labriola, Brandon Hill, Vlad Ratziu

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399461472

Cites:

Cited by: 15

Related to: 10